AstraZeneca Sends NDA for sustained release formulation of Seroquel for schizophrenia treatmentPrecautions include the risk of seizures, orthostatic hypotension and cataract development.The most frequently reported adverse events with the use of SEROQUEL in clinical trials were somnolence, dry mouth, dizziness, constipation, fatigue, abdominal pain, postural hypotension, pharyngitis, SGPT increased, dyspepsia, and weight gain.

AstraZeneca in the in the Dow Jones Sustainability Index as well the FTSE4Good. Index.. ABOUT ASTRAZENECAAstraZeneca is a major international healthcare companies in the research, development, forward-looking statements and marketing of prescription pharmaceuticals and healthcare services involved It is one of the world’s leading pharmaceutical companies with sales of $ 23950000000 and leading positions in. Sales of gastrointestinal oncology cardiovascular, respiratory, neuroscience, oncology and infection products. In the United States, AstraZeneca is a $ 10770000000 healthcare business with more than 12,000 employees.Add its submission to the National Health and Hospital reform Commission , warn to the AMA, that the linking of the public hospital funding accountability and performance benchmark will not automatically to good health findings.